5.15 USD
-0.15 (-2.83%)
5.1604 USD
+0.01 (+0.2%)
MDXG gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. MDXG has an excellent financial health rating, but there are some minor concerns on its profitability. MDXG may be a bit undervalued, certainly considering the very reasonable score on growth These ratings could make MDXG a good candidate for value investing.
1. Profitability
1.1 Basic Checks
- In the past year MDXG was profitable.
- MDXG had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: MDXG reported negative net income in multiple years.
- In multiple years MDXG reported negative operating cash flow during the last 5 years.
1.2 Ratios
- The Return On Assets of MDXG (12.80%) is better than 94.48% of its industry peers.
- MDXG has a better Return On Equity (17.09%) than 95.05% of its industry peers.
- MDXG has a Return On Invested Capital of 15.15%. This is amongst the best in the industry. MDXG outperforms 95.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.8% | ||
| ROE | 17.09% | ||
| ROIC | 15.15% |
ROA(3y)4.7%
ROA(5y)-7.18%
ROE(3y)1.74%
ROE(5y)-20.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- MDXG has a Profit Margin of 10.38%. This is amongst the best in the industry. MDXG outperforms 91.43% of its industry peers.
- With an excellent Operating Margin value of 13.73%, MDXG belongs to the best of the industry, outperforming 92.95% of the companies in the same industry.
- In the last couple of years the Operating Margin of MDXG has remained more or less at the same level.
- MDXG has a Gross Margin of 81.99%. This is amongst the best in the industry. MDXG outperforms 85.71% of its industry peers.
- MDXG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.73% | ||
| PM (TTM) | 10.38% | ||
| GM | 81.99% |
OM growth 3YN/A
OM growth 5Y-1.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.19%
GM growth 5Y-0.67%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MDXG is still creating some value.
- MDXG has more shares outstanding than it did 1 year ago.
- MDXG has more shares outstanding than it did 5 years ago.
- MDXG has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 7.99 indicates that MDXG is not in any danger for bankruptcy at the moment.
- MDXG has a better Altman-Z score (7.99) than 78.67% of its industry peers.
- MDXG has a debt to FCF ratio of 0.27. This is a very positive value and a sign of high solvency as it would only need 0.27 years to pay back of all of its debts.
- MDXG's Debt to FCF ratio of 0.27 is amongst the best of the industry. MDXG outperforms 95.43% of its industry peers.
- A Debt/Equity ratio of 0.07 indicates that MDXG is not too dependend on debt financing.
- With a Debt to Equity ratio value of 0.07, MDXG is not doing good in the industry: 61.14% of the companies in the same industry are doing better.
- Although MDXG does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.27 | ||
| Altman-Z | 7.99 |
ROIC/WACC1.73
WACC8.75%
2.3 Liquidity
- MDXG has a Current Ratio of 4.41. This indicates that MDXG is financially healthy and has no problem in meeting its short term obligations.
- MDXG has a Current ratio of 4.41. This is comparable to the rest of the industry: MDXG outperforms 50.86% of its industry peers.
- A Quick Ratio of 3.95 indicates that MDXG has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 3.95, MDXG is in line with its industry, outperforming 48.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.41 | ||
| Quick Ratio | 3.95 |
3. Growth
3.1 Past
- MDXG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.71%.
- The Revenue has grown by 14.77% in the past year. This is quite good.
- Measured over the past years, MDXG shows a small growth in Revenue. The Revenue has been growing by 3.11% on average per year.
EPS 1Y (TTM)-35.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)14.77%
Revenue growth 3Y10.5%
Revenue growth 5Y3.11%
Sales Q2Q%35.3%
3.2 Future
- MDXG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.54% yearly.
- Based on estimates for the next years, MDXG will show a quite strong growth in Revenue. The Revenue will grow by 14.49% on average per year.
EPS Next Y47.72%
EPS Next 2Y-7.17%
EPS Next 3Y16.54%
EPS Next 5YN/A
Revenue Next Year18%
Revenue Next 2Y7.11%
Revenue Next 3Y9.76%
Revenue Next 5Y14.49%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 14.31, MDXG is valued correctly.
- 96.38% of the companies in the same industry are more expensive than MDXG, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of MDXG to the average of the S&P500 Index (28.60), we can say MDXG is valued slightly cheaper.
- With a Price/Forward Earnings ratio of 20.61, MDXG is valued on the expensive side.
- Based on the Price/Forward Earnings ratio, MDXG is valued cheaply inside the industry as 93.52% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Forward Earnings ratio of 25.83, MDXG is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.31 | ||
| Fwd PE | 20.61 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MDXG indicates a rather cheap valuation: MDXG is cheaper than 97.71% of the companies listed in the same industry.
- MDXG's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MDXG is cheaper than 98.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.42 | ||
| EV/EBITDA | 9.31 |
4.3 Compensation for Growth
- MDXG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of MDXG may justify a higher PE ratio.
- A more expensive valuation may be justified as MDXG's earnings are expected to grow with 16.54% in the coming years.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y-7.17%
EPS Next 3Y16.54%
5. Dividend
5.1 Amount
- No dividends for MDXG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
MIMEDX GROUP INC / MDXG FAQ
Can you provide the ChartMill fundamental rating for MIMEDX GROUP INC?
ChartMill assigns a fundamental rating of 6 / 10 to MDXG.
Can you provide the valuation status for MIMEDX GROUP INC?
ChartMill assigns a valuation rating of 7 / 10 to MIMEDX GROUP INC (MDXG). This can be considered as Undervalued.
What is the profitability of MDXG stock?
MIMEDX GROUP INC (MDXG) has a profitability rating of 6 / 10.
What is the financial health of MIMEDX GROUP INC (MDXG) stock?
The financial health rating of MIMEDX GROUP INC (MDXG) is 7 / 10.
What is the earnings growth outlook for MIMEDX GROUP INC?
The Earnings per Share (EPS) of MIMEDX GROUP INC (MDXG) is expected to grow by 47.72% in the next year.